InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by Dr Bill Larkins. Director active across 1 company, notably Hikma Pharmaceuticals PLC. Cumulatively, 2 filings have been logged. Activity tracked since 30 May 2025. The latest transaction was disclosed on 4 June 2025 (Sale). Regulator: RNS (LSE). All data is openly available.
2 of 2 declarations